CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...
Hence then, the article about smart trial two year data continues to demonstrate superior valve performance for evolut tavr system in small annulus patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients )
Also on site :
- LSG vs RCB Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- IPL 2026, Match 50
- McDonald’s is about to report earnings. Here’s what to expect
- He was ‘The Mouth of the South’ and ‘Captain Outrageous,’ but Ted Turner said ‘If only I had a little humility, I’d be perfect’